The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions manufactured by ...
A new "powerful tool" for combatting opioid deaths isn't settled science. For that reason, the state is taking a measured ...
For patients with allergic rhinitis, twice-daily azelastine plus fluticasone cut nasal symptoms ... all treatments were administered as one spray twice daily to preserve blinding.
Findings from an exploratory 2a study showed improvements in patients with cancer cachexia with PH284 compared with placebo.